z-logo
open-access-imgOpen Access
A patient with relapsed high-grade serous ovarian carcinoma with somatic RAD51C mutations treated with PARPi monotherapy: a case report
Author(s) -
SiewFei Ngu,
Hys Ngan,
Karen K. L. Chan
Publication year - 2022
Publication title -
cancer drug resistance
Language(s) - English
Resource type - Journals
ISSN - 2578-532X
DOI - 10.20517/cdr.2022.12
Subject(s) - medicine , olaparib , ovarian cancer , ovarian carcinoma , chemotherapy , oncology , serous fluid , serous carcinoma , radiology , cancer , biochemistry , chemistry , polymerase , poly adp ribose polymerase , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom